Viewing Study NCT06104618


Ignite Creation Date: 2025-12-25 @ 5:04 AM
Ignite Modification Date: 2026-03-02 @ 5:19 PM
Study NCT ID: NCT06104618
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2023-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module